Clearside Biomedical【CLSD】株式ニュース

名称	銘柄コード	市場	種別
Clearside Biomedical Inc	CLSD	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.06	-5.08%	1.12	13:00:02

始値	安値	高値	終値	前日終値
1.17	1.12	1.21	1.12	1.18

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/12	20:05	GLOBE	Clearside Biomedical’s Leadership in Suprachoroidal Delivery..
2024/5/21	20:05	GLOBE	Clearside Biomedical Announces Publication of Consensus..
2024/5/11	05:31	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/5/10	05:10	EDGAR2	Form 8-K - Current report
2024/5/10	05:05	GLOBE	Clearside Biomedical Announces First Quarter 2024 Financial..
2024/5/09	05:15	GLOBE	Clearside Biomedical to Participate in Fireside Chat at the..
2024/4/30	20:05	GLOBE	Clearside Biomedical to Report First Quarter 2024 Financial..
2024/4/16	20:05	GLOBE	Clearside Biomedical Appoints Seasoned Biotechnology..
2024/4/02	20:05	GLOBE	Clearside Biomedical to Participate in Fireside Chat at the..
2024/3/18	20:05	GLOBE	Clearside Biomedical Appoints Victor Chong, M.D., MBA as..
2024/3/13	05:05	GLOBE	Clearside Biomedical Announces Fourth Quarter and Full Year..
2024/2/29	21:05	GLOBE	Clearside Biomedical to Report Fourth Quarter and Full Year..
2024/2/09	07:05	EDGAR2	Form 8-K - Current report
2024/2/09	06:52	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/07	22:00	GLOBE	Clearside Biomedical Announces Pricing of $15 Million..
2024/2/02	06:01	EDGAR2	Form 8-K - Current report
2024/1/20	08:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	05:04	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/29	06:10	EDGAR2	Form 8-K - Current report
2023/12/14	21:05	GLOBE	Clearside Biomedical Reports Significant Progress in ODYSSEY..
2023/11/14	06:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14	06:10	EDGAR2	Form 8-K - Current report
2023/11/14	06:05	GLOBE	Clearside Biomedical Announces Third Quarter 2023 Financial..
2023/11/08	21:05	GLOBE	Clearside Biomedical to Participate in Fireside Chat at the..
2023/11/08	06:20	GLOBE	Clearside Biomedical’s Versatile Suprachoroidal Injection..
2023/11/04	01:01	EDGAR2	Form 8-K - Current report
2023/11/04	01:00	GLOBE	BioCryst and Clearside Biomedical Enter Partnership to..
2023/11/02	20:05	GLOBE	Clearside Biomedical Announces Presentations at the American..
2023/11/01	20:05	GLOBE	Clearside Biomedical Completes Recruitment in ODYSSEY Phase..
2023/10/31	20:05	GLOBE	Clearside Biomedical to Report Third Quarter 2023 Financial..
2023/10/16	20:05	GLOBE	Clearside Biomedical Positive OASIS and Extension Study Data..
2023/10/04	22:00	GLOBE	Clearside Biomedical Announces Advancement of XIPERE® in..
2023/10/04	05:35	GLOBE	Clearside Biomedical to Participate in a Panel Discussion at..
2023/9/30	05:46	EDGAR2	Form 8-K - Current report
2023/9/26	05:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/23	05:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/21	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/19	20:05	GLOBE	Clearside Biomedical to Participate in Panel Discussion at..
2023/9/14	07:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	05:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/15	05:11	EDGAR2	Form 8-K - Current report
2023/8/15	05:05	GLOBE	Clearside Biomedical Announces Second Quarter 2023 Financial..
2023/8/03	05:30	GLOBE	Clearside Biomedical to Participate in Upcoming Investor..
2023/8/01	20:05	GLOBE	Clearside Biomedical to Report Second Quarter 2023 Financial..
2023/7/31	20:05	GLOBE	Clearside Biomedical Highlights Excellent Safety Profile of..
2023/7/20	20:05	GLOBE	Clearside Biomedical’s Suprachoroidal Injection Platform to..
2023/7/17	20:05	GLOBE	Clearside Biomedical Announces Enrollment of Multiple..
2023/7/12	05:05	GLOBE	Clearside Biomedical CEO George Lasezkay to Present at the..
2023/7/10	20:05	GLOBE	Clearside Biomedical Asia-Pacific Partner Arctic Vision..